Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab is a cancer drug developer, best known for its antibody technology platforms, DuoBody and HexaBody, and its promising first-in-class multiple myeloma drug Darzalex (daratumumab), which is partnered with Johnson & Johnson. The company also has several pipeline candidates targeting other oncologic indications and autoimmune diseases.

Contact Information

Website: www.genmab.com
Email: r.gravesen@genmab.com
Main Phone: +45 70202728
Address: Kalvebod Brygge 43
Address 2: 1560
City / Town: Copenhagen V
Country: DNK
Postal Code: 1560

Issuer Information

Exchange: OTO
Employees: 377


Gathering Data... Please wait

Profile

Genmab is a cancer drug developer, best known for its antibody technology platforms, DuoBody and HexaBody, and its promising first-in-class multiple myeloma drug Darzalex (daratumumab), which is partnered with Johnson & Johnson. The company also has several pipeline candidates targeting other oncologic indications and autoimmune diseases.

Contact Information

Website: www.genmab.com
Email: r.gravesen@genmab.com
Main Phone: +45 70202728
Address: Kalvebod Brygge 43
Address 2: 1560
City / Town: Copenhagen V
Country: DNK
Postal Code: 1560

Issuer Information

Exchange: OTO
Employees: 377
$ 16.94 $ -0.085 (-0.50%)
Last Price 16.94 Change $ -0.085 Change % -0.50 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 17.08 High 17.09 Low 16.91 Prev Close 17.03
Last Trade Volume 20,367 52 Wk Hi 21.24 52 Wk Low 12.10
Market Cap 10.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 613,463,180.00 EPS (TTM) 0.37 PE Ratio 47.50 Exchange OTCPK